Bai X, Zhu M, He Y, Wang T, Tian D, Shu J (2022) The impacts of probiotics in eradication therapy of Helicobacter pylori. Arch Microbiol 204:692. https://doi.org/10.1007/s00203-022-03314-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beresniak A, Malfertheiner P, Franceschi F, Liebaert F, Salhi H, Gisbert JP (2020) Helicobacter pylori “Test-and-Treat” strategy with urea breath test: a cost-effective strategy for the management of dyspepsia and the prevention of ulcer and gastric cancer in Spain-Results of the Hp-Breath initiative. Helicobacter 25:e12693. https://doi.org/10.1111/hel.12693

Article  PubMed  Google Scholar 

Chen Y-C, Malfertheiner P, Yu H-T, Kuo C-L, Chang Y-Y, Meng F-T, Wu Y-X, Hsiao J-L, Chen M-J, Lin K-P, Wu C-Y, Lin J-T, O’Morain C, Megraud F, Lee W-C, El-Omar EM, Wu M-S, Liou J-M (2024) Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022. Gastroenterology 166:605–619. https://doi.org/10.1053/j.gastro.2023.12.022

Article  PubMed  Google Scholar 

Cunningham M, Azcarate-Peril MA, Barnard A, Benoit V, Grimaldi R, Guyonnet D, Holscher HD, Hunter K, Manurung S, Obis D, Petrova MI, Steinert RE, Swanson KS, van Sinderen D, Vulevic J, Gibson GR (2021) Shaping the future of probiotics and prebiotics. Trends Microbiol 29:667–685. https://doi.org/10.1016/j.tim.2021.01.003

Article  CAS  PubMed  Google Scholar 

Fakharian F, Sadeghi A, Pouresmaeili F, Soleimani N, Yadegar A (2023) Immunomodulatory effects of live and pasteurized Lactobacillus crispatus strain RIGLD-1 on Helicobacter pylori-triggered inflammation in gastric epithelial cells in vitro. Mol Biol Rep 50:6795–6805. https://doi.org/10.1007/s11033-023-08596-x

Article  CAS  PubMed  Google Scholar 

Fakharian F, Sadeghi A, Pouresmaeili F, Soleimani N, Yadegar A (2024) Anti-inflammatory effects of extracellular vesicles and cell-free supernatant derived from Lactobacillus crispatus strain RIGLD-1 on Helicobacter pylori-induced inflammatory response in gastric epithelial cells in vitro. Folia Microbiol 69:927–939. https://doi.org/10.1007/s12223-024-01138-3

Article  CAS  Google Scholar 

Francavilla R, Lionetti E, Castellaneta SP, Magistà AM, Maurogiovanni G, Bucci N, De Canio A, Indrio F, Cavallo L, Ierardi E, Miniello VL (2008) Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study. Helicobacter 13:127–134. https://doi.org/10.1111/j.1523-5378.2008.00593.x

Article  PubMed  Google Scholar 

Hibbing ME, Fuqua C, Parsek MR, Peterson SB (2010) Bacterial competition: surviving and thriving in the microbial jungle. Nat Rev Microbiol 8:15–25. https://doi.org/10.1038/nrmicro2259

Article  CAS  PubMed  PubMed Central  Google Scholar 

Holz C, Busjahn A, Mehling H, Arya S, Boettner M, Habibi H, Lang C (2015) Significant reduction in Helicobacter pylori load in humans with non-viable Lactobacillus reuteri DSM17648: a pilot study. Probiotics Antimicrob Proteins 7:91–100. https://doi.org/10.1007/s12602-014-9181-3

Article  PubMed  Google Scholar 

Ismail NI, Nawawi KNM, Hsin DCC, Hao KW, Mahmood NRKN, Chearn GLC, Wong Z, Tamil AM, Joseph H, Raja Ali RA (2023) Probiotic containing Lactobacillus reuteri DSM 17648 as an adjunct treatment for Helicobacter pylori infection: a randomized, double-blind, placebo-controlled trial. Helicobacter 28:e13017. https://doi.org/10.1111/hel.13017

Article  CAS  PubMed  Google Scholar 

Lionetti E, Miniello VL, Castellaneta SP, Magistá AM, de Canio A, Maurogiovanni G, Ierardi E, Cavallo L, Francavilla R (2006) Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial. Aliment Pharmacol Ther 24:1461–1468. https://doi.org/10.1111/j.1365-2036.2006.03145.x

Article  CAS  PubMed  Google Scholar 

Liu X, Chu K-M (2014) E-Cadherin and gastric cancer: cause, consequence, and applications. BioMed Res Int 2014:637308. https://doi.org/10.1155/2014/637308

Article  CAS  PubMed  PubMed Central  Google Scholar 

Malfertheiner P, Camargo MC, El-Omar E, Liou J-M, Peek R, Schulz C, Smith SI, Suerbaum S (2023) Helicobacter pylori infection. Nat Rev Dis Primers 9:19. https://doi.org/10.1038/s41572-023-00431-8

Article  PubMed  PubMed Central  Google Scholar 

Malfertheiner P, Megraud F, Rokkas T, Gisbert JP, Liou JM, Schulz C, Gasbarrini A, Hunt RH, Leja M, O'Morain C, Rugge M, Suerbaum S, Tilg H, Sugano K, El-Omar EM, European Helicobacter and Microbiota Study Group (2022) Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut 71:1724-1762.https://doi.org/10.1136/gutjnl-2022-327745

Moonwiriyakit A, Pathomthongtaweechai N, Steinhagen PR, Chantawichitwong P, Satianrapapong W, Pongkorpsakol P (2023) Tight junctions: from molecules to gastrointestinal diseases. Tissue Barriers 11:2077620. https://doi.org/10.1080/21688370.2022.2077620

Article  CAS  PubMed  Google Scholar 

Nabavi-Rad A, Jamshidizadeh S, Azizi M, Yadegar A, Robinson K, Monaghan TM, Zali MR (2023) The synergistic effect of Levilactobacillus brevis IBRC-M10790 and vitamin D3 on Helicobacter pylori-induced inflammation. Front Cell Infect Microbiol 13:1171469. https://doi.org/10.3389/fcimb.2023.1171469

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nabavi-Rad A, Sadeghi A, Asadzadeh Aghdaei H, Yadegar A, Smith SM, Zali MR (2022) The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management. Gut Microbes 14:2108655. https://doi.org/10.1080/19490976.2022.2108655

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ojetti V, Bruno G, Ainora ME, Gigante G, Rizzo G, Roccarina D, Gasbarrini A (2012) Impact of Lactobacillus reuteri supplementation on anti-Helicobacter pylori levofloxacin-based second-line therapy. Gastroenterol Res Pract 2012:740381. https://doi.org/10.1155/2012/740381

Article  PubMed  PubMed Central  Google Scholar 

Ong L-L, Lin C-H (2024) Adhesion, infection, and therapeutic treatment of Helicobacter pylori: a review on current aspects and future promise. Discov Appl Sci 6:323. https://doi.org/10.1007/s42452-024-05923-0

Article  CAS  Google Scholar 

Pawar K, Aranha C (2022) Lactobacilli metabolites restore E-cadherin and suppress MMP9 in cervical cancer cells. Curr Res Toxicol 3:100088. https://doi.org/10.1016/j.crtox.2022.100088

Article  CAS  PubMed  PubMed Central  Google Scholar 

Philipp L-M, Yesilyurt U-U, Surrow, A, Künstner A, Mehdorn A-S, Hauser C, Gundlach J-P, Will O, Hoffmann P, Stahmer L, Franzenburg S, Knaack H, Schumacher U, Busch H, Sebens S (2024) Epithelial and mesenchymal-like pancreatic cancer cells exhibit different stem cell phenotypes associated with different metastatic propensities. Cancers 16:686. https://www.mdpi.com/2072-6694/16/4/686

Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E (2018) Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions. Gastroenterology 155:1372-1382.e1317. https://doi.org/10.1053/j.gastro.2018.07.007

Article  PubMed  Google Scholar 

Scaccianoce G, Zullo A, Hassan C, Gentili F, Cristofari F, Cardinale V, Gigliotti F, Piglionica D, Morini S (2008) Triple therapies plus different probiotics for Helicobacter pylori eradication. Eur Rev Med Pharmacol Sci 12:251–256

CAS  PubMed  Google Scholar 

Schmidt TP, Perna AM, Fugmann T, Böhm M, Jan H, Haller S, Götz C, Tegtmeyer N, Hoy B, Rau TT, Neri D, Backert S, Schneider G, Wessler S (2016) Identification of E-cadherin signature motifs functioning as cleavage sites for Helicobacter pylori HtrA. Sci Rep 6:23264. https://doi.org/10.1038/srep23264

Article  CAS  PubMed  PubMed Central  Google Scholar 

Suez J, Zmora N, Segal E, Elinav E (2019) The pros, cons, and many unknowns of probiotics. Nat Med 25:716–729. https://doi.org/10.1038/s41591-019-0439-x

Article  CAS  PubMed  Google Scholar 

Tshibangu-Kabamba E, Yamaoka Y (2021) Helicobacter pylori infection and antibiotic resistance — from biology to clinical implications. Nat Rev Gastroenterol Hepatol 18:613–629. https://doi.org/10.1038/s41575-021-00449-x

Article  PubMed  Google Scholar 

Yarmohammadi M, Yadegar A, Ebrahimi MT, Zali MR (2021) Effects of a potential probiotic strain Lactobacillus gasseri ATCC 33323 on Helicobacter pylori-induced inflammatory response and gene expression in coinfected gastric epithelial cells. Probiotics Antimicrob Proteins 13:751–764. https://doi.org/10.1007/s12602-020-09721-z

Article  CAS  PubMed  Google Scholar 

Zhang M, Zhang C, Zhao J, Zhang H, Zhai Q, Chen W (2020) Meta-analysis of the efficacy of probiotic-supplemented therapy on the eradication of H. pylori and incidence of therapy-associated side effects. Microb Pathog 147:104403. https://doi.org/10.1016/j.micpath.2020.104403